Oral Lipid Nanoparticle Drug Can Prevent Development of Colitis-Associated Cancer, Researchers Find
Oral Lipid Nanoparticle Drug Can Prevent Development of Colitis-Associated Cancer, Researchers Find
An oral lipid nanoparticle drug prevents tumor development in mice, suggesting this is a promising drug formulation for preventing colitis-associated cancer, according to a study led by researchers in the Institute for Biomedical Sciences at Georgia State University.










